Fatty liver disease prevalence leads pharma companies look to first in-class drugs
According to GBI Research, fatty liver disease has increased rapidly in the past several decades and is now estimated at 20-45 per…
Author
Global cancer supportive care therapeutics market to see negligible growth to $12.4 billion by 2022
According to GBI Research, negligible growth can be attributed to the patent expiries of some of the therapy area’s most…
Rooting out Rubella: Making it Mission Possible
The government needs to quash fears about safety of the rubella vaccine and establish its efficacy to achieve its goal of…
5th Annual Pharma Project Management Conference held in Mumbai
The two-day event threw light on diverse facets and challenges of project management through a conference - workshop model
PharmaTech Expo to be held in Chandigarh
The event from April 11-13, 2017 will see participation from over 3000 plus visitors
IPM valued at Rs 9,032 crores in Feb 2017
Domestic companies continued to dominate the market with a 78 per cent share in MAT February 2017 with a growth of 10 per cent
KU Leuven to develop dual vaccine against yellow fever and rabies
The RABYD-VAX consortium, led by KU Leuven (University of Leuven, Belgium), has started developing a cheap, temperature-stable,…
Cipla receives US FDA approval for generic Epzicom tabs
The tablets in combination with other antiretroviral agents are used for the treatment of HIV-1 infection
US FDA agrees to abridged clinical Phase III for Wockhardt’s WCK 5222
A combination of Zidebactam and Cefepime, WCK 5222 represents a new class of antibiotic treatment for AMR